T-cell repertoire diversity: friend or foe for protective antitumor response?
Authors:
Open Access
- 22 December 2022
- journal article
- review article
- Published by Springer Nature in Journal of Experimental & Clinical Cancer Research
- Vol. 41 (1) , 1-16
Abstract
Profiling the T-Cell Receptor (TCR) repertoire is establishing as a potent approach to investigate autologous and treatment-induced antitumor immune response. Technical and computational breakthroughs, including high throughput next-generation sequencing (NGS) approaches and spatial transcriptomics, are providing unprecedented insight into the mechanisms underlying antitumor immunity. A precise spatiotemporal variation of T-cell repertoire, which dynamically mirrors the functional state of the evolving host-cancer interaction, allows the tracking of the T-cell populations at play, and may identify the key cells responsible for tumor eradication, the evaluation of minimal residual disease and the identification of biomarkers of response to immunotherapy. In this review we will discuss the relationship between global metrics characterizing the TCR repertoire such as T-cell clonality and diversity and the resultant functional responses. In particular, we will explore how specific TCR repertoires in cancer patients can be predictive of prognosis or response to therapy and in particular how a given TCR re-arrangement, following immunotherapy, can predict a specific clinical outcome. Finally, we will examine current improvements in terms of T-cell sequencing, discussing advantages and challenges of current methodologies.Keywords
Funding Information
- Lazio Innova (A0320-2019-28097)
- Associazione Italiana per la Ricerca sul Cancro (IG 19822)
- Ministero della Salute (Alliance Against Cancer: “Research project on CAR T cells for hematological malignancies, solid tumors”, National personalized oncology program for the IRCCS of the ACC network)
This publication has 155 references indexed in Scilit:
- IgBLAST: an immunoglobulin variable domain sequence analysis toolNucleic Acids Research, 2013
- Timing and Magnitude of Type I Interferon Responses by Distinct Sensors Impact CD8 T Cell Exhaustion and Chronic Viral InfectionCell Host & Microbe, 2012
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion SequencingNew England Journal of Medicine, 2012
- SoDA2: a Hidden Markov Model approach for identification of immunoglobulin rearrangementsBioinformatics, 2010
- Next-generation DNA sequencingNature Biotechnology, 2008
- The new paradigm of flow cell sequencing: Table 1.Genome Research, 2008
- Immunological aspects of cancer chemotherapyNature Reviews Immunology, 2008
- Cancer Regression in Patients After Transfer of Genetically Engineered LymphocytesScience, 2006
- The many important facets of T-cell repertoire diversityNature Reviews Immunology, 2004
- Cancer immunoediting: from immunosurveillance to tumor escapeNature Immunology, 2002